hexestrol has been researched along with cyproterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masaki, T; Masuoka, M; Nakayama, R; Shimamoto, K | 1 |
| Bauss, F; Feldmann, S; Lempert, UG; Minne, HW; Parvizi, S; Pfeifer, M; Ziegler, R | 1 |
2 other study(ies) available for hexestrol and cyproterone
| Article | Year |
|---|---|
Anti-androgen TSAA-291. I. Anti-androgenic effects of a new steroid TSAA-291 (16 beta-ethyl-17 beta-hydroxy-4-oestren-3-one) and its derivatives.
Topics: Androgen Antagonists; Androstenedione; Animals; Castration; Chemical Phenomena; Chemistry; Chlormadinone Acetate; Cyproterone; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Estradiol; Hexestrol; Injections, Subcutaneous; Male; Nandrolone; Organ Size; Prostate; Rats; Seminal Vesicles; Testis; Testosterone | 1979 |
Antiestrogen and antiandrogen administration reduce bone mass in the rat.
Topics: Androgen Antagonists; Animals; Bone Density; Bone Diseases, Metabolic; Cyproterone; Cyproterone Acetate; Estrogen Antagonists; Female; Hexestrol; Male; Orchiectomy; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Tamoxifen; Testosterone | 1989 |